🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out our most recent in #OpenForumInfectiousDiseases looking at US antibiotic marketplace vs. top 10 US drugs. Entire branded abx market: $750 M/yr. Humira alone >$13 B in US! Abx are 0.2% of US drug market. Something's out of whack. IDSA #AMR academic.oup.com/ofid/advance-a…

2019 quite similar trend Humira is still the world’s best-selling drug Oncology and Immunology are dominating the market #IDTwitter #COVID19

podcasts.apple.com/us/podcast/bre…

When you’re in a rush to learn something and you find the perfect YouTube video 🙌🏻

1/14 Why doesn't daptomycin treat pneumonia? The answer also explains why dapto raises serum CK levels. #medtwitter #tweetorial

I began my medical career at the height of the HIV/AIDS crisis, and I've spent my life ever since working to research, treat, and combat infectious diseases. I'm honored to be called to lead the brilliant team at the CDC. We are ready to combat this virus with science and facts.

I have never seen #MedTwitter as collectively happy as it is after hearing Rochelle Walensky, MD, MPH to lead the CDC.

Is Posaconazole the ultimate answer for IFI prophylaxis? What is the role of vori or even echinocandins. Really interesting meta-analysis. Vori better for HSCT and Posa for AML/MDS?? jamanetwork.com/journals/jaman…

Come join our amazing team! And spend time with me for an Immunocompromised ID rotation in our HemeOnc and BMT patients at the Miami Cancer Institute! Lots of opportunities for a resident to make an impact! Kelsey Williams Jefferson Cua Wilbert J Fuerte PharmD, BCIDP Jason Morell

Wahoo! Long-acting injectable CAB + RPV got an FDA label update today. Oral lead in is now optional!!!

#IDTwitter #SIDPharm #MedEd #MedTwitter 1/ #Biostatistics and #Epidemiology rounds discussion on pre- and post-testing probabilities and likelihood ratios. How to quickly determine these numbers in practice! (*2x2 table and formulas added for reference)

Amazing work everyone! Great to finally get this out there!

Micafungin as primary antifungal prophylaxis in AML/MDS patients receiving venetoclax-based regimens demonstrates a comparable incidence of IFI at 90 days to previous studies reporting similar outcomes. Williams Monier Texidor, PharmD, BCIDP Bug Pharmacist 💊🧫 Tim Gauthier Lee Amaya #SIDP2024 #IDWeek2024 (6/9)